EDC



News

AmberCRO has been awarded by the Latvian Governmental Institution (LIAA) ...[more]


AmberCRO has been selected as one of 10 Country Representatives ...[more]


AmberCRO is planning first Clinical Trials in Belarus ... [more]


AmberCRO has received appreciation for successful collaboration with the German companies ... [more]


AmberCRO had received ISO 9001:2008 ... [more]


 
Our Experience
 

Our experience is based on many clinical trials performed with high quality (Phase I, Phase II, Phase III, Phase IV studies).

Clinical studies with Investigational Medical Product (Adults)

Clinical studies with children (12-17 years old and 6-12 years old)

Clinical studies with devices

Anti Infective 

  • Hepatitis C

Respiratory

  • Asthma (12Y-17Y)

  • Asthma (6Y-12Y)

Surgery 

 

  • Venous leg Ulcers (Device)

Cardiology 

  • Arterial Hypertension
  • Sever/Moderate Arterial Hypertension

Surgery 

  • Complicated Intra Abdominal infections (12Y-17Y)

  • Complicated Intra Abdominal infections (6Y-11Y)

Cardiology

  • Arterial Hypertension
  • Sever  Arterial Hypertension

Genetic diseases 

  • Cystic Fibrosis
  • Alpha-1 antitrypsin deficiency

 

 

Dermatology 

  • Onychomycosis
  • Psoriasis

 

 

Oncology 

  • Prostate Cancer (Phase II)
  • Prostate Cancer
  • Brest cancer

 

 

Anti Inflammatory

  • Osteoarthritis
  • Knee Osteoarthritis
  • Ulcerative colitis (remission phase)
  • Complicated Intra abdominal Infection

 

 

Neurology

  • Parkinson's disease

 

 

Endocrinology

  • Diabetes Mellitus Type II (phase I)
  • Diabetes Mellitus Type II (phase III)
  • Diabetes Mellitus Type II (phase III)

 

 

Ophthalmology

  • Wet -  AMD

 

 

Pulmonary diseases

  • Asthma
  • Asthma
  • COPD

 

 

Surgery

  • Acute Venous Thromboembolism in Cancer Patients

 

 

 


 
 
© copyright AmberCRO 2007